20th International Congress » Parkinson's disease: Neuroimaging and neurophysiology

Date: Wednesday, June 22, 2016

Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:00pm-1:30pm: A cognitive fMRI study of non-manifesting LRRK2 and GBA carriers

A. Thaler, N. Bregman, A. Mirelman, T. Gurevich, M. Gana-Weiss, A. Orr-Urtreger, T. Hendler, N. Giladi (Tel-Aviv, Israel)

12:00pm-1:30pm: A longitudinal study of functional deterioration of primary olfactory cortex in early-stage Parkinson’s disease

J. Wang, Z. Mosher, T. Subramanian, Q.X. Yang (Hershey, PA, USA)

12:00pm-1:30pm: Alterations in muscle synergies in early stage Parkinson’s disease

J.F. Daneault, G. Vergara-Diaz, C. Adans-Dester, G. Ferreira-Carvalho, V.C.K. Cheung, P. Bonato (Charlestown, MA, USA)

12:00pm-1:30pm: Altered brain activation in complex walking conditions in patients with Parkinson’s disease

I. Maidan, K. Rosenberg-Katz, Y. Jacob, N. Giladi, J.E. Deutsch, A. Mirelman, J.M. Hausdorff (Tel Aviv, Israel)

12:00pm-1:30pm: Altered resting-state functional interhemispheric connectivity in Parkinson’s disease

X. Dan, S. Lin, A. Liu, Z. Wang, M.J. McKeown, P. Chan (Beijing, People's Republic of China)

12:00pm-1:30pm: Assessment of brainstem function with blink reflex variations in Parkinson’s disease

D. Weise, C. Pargac, J.J. Rumpf, C. Fricke, J. Classen (Leipzig, Germany)

12:00pm-1:30pm: Behavioral and neuroimaging effects of LSVT-BIG and conventional physiotherapy in Parkinson’s disease

F. Schaible, F. Schwartz, T. v. Eimeren, C. Eggers (Köln, Germany)

12:00pm-1:30pm: Botulinum toxin treatment of freezing of gait in Parkinson’s disease patients as reflected in functional magnetic resonance imaging of leg movement

M. Vaštík, P. Hok, P. Hluštík, P. Kanovský, Z. Tüdös (Olomouc, Czech Republic)

12:00pm-1:30pm: Brain iron levels in Parkinson’s disease by postmortem and MRI measurements: A systematic review and meta-analysis

J.Y. Wang, Q.Q. Zhuang, L.B. Zhu, H. Zhu, T. Li, X. Zhang, J.H. Zhu (Wenzhou, People's Republic of China)

12:00pm-1:30pm: Brain mechanisms underlying visual processing in Parkinson’s disease

I. Rektorova, N. Elfmarkova, M. Gajdos, R. Marecek, S. Rapcsak (Brno, Czech Republic)

12:00pm-1:30pm: Changes of brain structure and cognition in individuals with possible prodromal Parkinson’s disease

M. Heldmann, J. Heeren, L. Rauch, C. Klein, T.F. Münte, M. Kasten, N. Brüggemann (Lübeck, Germany)

12:00pm-1:30pm: Characterization and quantitative analysis of prelemniscal radiations in Parkinson´s disease

M.G. Garcia-Gomar, I. Vaca-Palomares, M. Esqueda, J. Soto, J.D. Tournier, L. Concha, F. Velasco (Queretaro, Mexico)

12:00pm-1:30pm: Combined effects of visual and auditory cues on gait initiation in Parkinson’s disease

T. Hashimoto, H. Sato (Matsumoto, Japan)

12:00pm-1:30pm: Comparative analysis of clinical and neuroimaging features of parkinsonism and dementia of Alzheimer’s type

D. Tolibov, G. Rakhimbaeva (Tashkent, Uzbekistan)

12:00pm-1:30pm: Comparison of DAT and DOPA PET tracer for assessing severity and progression in patients with Parkinson’s disease

W. Li, N.P. Lao-Kaim, A.A. Roussakis, A. Martin-Bastida, C. Loane, N. Valle-Guzman, Z. Kefalopoulou, M. Politis, T. Foltynie, R.A. Barker, P. Piccini (London, United Kingdom)

12:00pm-1:30pm: Comparison of DAT scan, cardiac MIBG scintigraphy, and cerebrospinal fluid 5HIAA levels in Parkinsonian syndrome

R. Sengoku, M. Yamazaki, D. Kaneda, Y. Nishina, A.M. Tokumaru, S. Murayama (Tokyo, Japan)

12:00pm-1:30pm: Corpus callosum thickness and area in Parkinson’s disease

I.O. Bledsoe, D. Merkitch, G. Stebbins, B. Bernard, J.G. Goldman (Chicago, IL, USA)

12:00pm-1:30pm: Correlation analysis for postural instability and autonomic dysfunction in patients with Parkinson’s disease

S. You, S.H. Lim, H. Lee, H.A. Kim (Dague, Korea)

12:00pm-1:30pm: Cortical atrophy in cognitively impaired Parkinson’s disease patients

M.M. Almuqbel, T.R. Melzer, D.J. Myall, M.R. MacAskill, L. Livingston, K. Wood, T.L. Pitcher, R.J. Keenan, J.C. Dalrymple-Alford, T.J. Andrson (Christchurch, New Zealand)

12:00pm-1:30pm: Cortical excitability in patients with Parkinson’s disease on levodopa carbidopa intestinal gel thereapy

S.D. Kim, S. Vucic, N. Mahant, M.C. Kiernan, V.S.C. Fung (Sydney, Australia)

12:00pm-1:30pm: Cortical phase amplitude coupling (PAC) identifies patterns in clinical states of Parkinson’s disease (PD) using magnetoencephalography (MEG)

E. Peña, S.A. Mian, L. Rosedahl, F.A.I. Mohammed, T.M. Mohammad, M.D. Johnson, J.A. Bajwa (Minneapolis, MN, USA)

12:00pm-1:30pm: Cortical thinning associated with mild cognitive impairment in Parkinson’s disease

S. Galantucci, F. Agosta, T. Stojkovic, I. Petrovic, E. Stefanova, E. Canu, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

12:00pm-1:30pm: Critical path for Parkinson’s II: Global regulatory agencies support the use of dopamine transporter neuroimaging as an enrichment biomarker to enable clinical trials in early Parkinson’s disease

D.T. Stephenson, S. Arneric, D. Babcock, P. Cole, T. Comery, M.F. Gordon, D. Grosset, D. Hill, S.Z. Imam, C.R. Jarecke, V. Kern, D. Matthews, R. Meibach, K. Romero, A. Roach, D. Russell, J. Seibyl, P. Sherwin, B.A. Sieber, L. Slicker, C. Sur, K. Marek (Tucson, AZ, USA)

12:00pm-1:30pm: DAT SPECT data of Parkinson’s disease patients with and without REM Sleep Pathology: A report from the DeNoPa cohort

M.L. Muntean, D. Leucuta, B. Mollenhauer, C. Trenkwalder, F. Sixel-Döring (Göttingen, Germany)

12:00pm-1:30pm: Density of metabotropic glutamate receptors subtype 1 in de novo patients with Parkinson’s disease using ¹¹C-ITMM PET

M. Mishina, M. Suzuki, K. Ishii, M. Sakata, K. Wagetsuma, K. Ishibashi, J. Toyohara, M.R. Zhang, K. Kimura, K. Ishiwata (Kawasaki, Japan)

12:00pm-1:30pm: Detecting brainstem changes in Parkinson’s disease using quantitative MRI

C. Lambert, A. Lutti, B. Draganski, T. Foltynie (London, United Kingdom)

12:00pm-1:30pm: Detection of primary olfactory cortex dysfunction in early-stage Parkinson’s disease

J. Wang, T. Subramanian, Q.X. Yang (Hershey, PA, USA)

12:00pm-1:30pm: Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging

C. Peralta, T. Soto Depetris, A. Perez, F. Biafore, J. Gili, A. Valda, D. Menna, M. Aguilar, H. Corradini, M. Bastianello (Caba, Argentina)

12:00pm-1:30pm: Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis with clinical considerations and neuroimaring parameters

C. Atkinson-Clement, S. Pinto, A. Eusebio, O. Coulon (Aix-en-Provence, France)

12:00pm-1:30pm: Diffusion tensor imaging of corticospinal tract, cingulum and corpus callosum in Parkinson’s disease (PD) patients

R. Guimarães, B. Campos, L. Campos, L. Piovesana, P. Azevedo, A. D'Abreu, F. Cendes (Campinas, Brazil)

12:00pm-1:30pm: Diffusion tensor imaging of the corticospinal tract differentiates Parkinson’s disease (PD) patients from controls

R. Guimaraes, B. Campos, L. Campos, L. Piovesana, P. Azevedo, A. D'Abreu, F. Cendes (Campinas, Brazil)

12:00pm-1:30pm: Diffusion tensor metrics of thalamic degeneration and postural instability in Parkinson’s disease

M. Petrou, C. Davatzikos, M. Muller, R. Koeppe, R. Albin, K. Frey, N. Bohnen (Ann Arbor, MI, USA)

12:00pm-1:30pm: Disrupted hubs in functional brain networks in subtype-specific Parkinson’s disease

L. Ma, H. Chen, T. Feng (Beijing, People's Republic of China)

12:00pm-1:30pm: Disrupted motor memory in Parkinson’s disease

S. Voets, J.S. Brittain, M. Panouilleres, C. Miall, N. Jenkinson (Birmingham, United Kingdom)

12:00pm-1:30pm: Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment

K. Kawabata, H. Watanabe, E. Bagarinao, N. Yoneyama, K. Hara, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

12:00pm-1:30pm: Does dopamine affect the selection of stepping actions in PD?

E. Mallia, C. Stummer, J. Rothwell, B.R. Bloem, V. Weerdesteyn (London, United Kingdom)

12:00pm-1:30pm: Dopamine and task-dependent evolution of oscillatory activity in the subthalamic nucleus (STN) and coupling between the STN local field potential and muscle activity in Parkinson’s disease

U. Ramirez Pasos, R. Reese, F. Steigerwald, M. Reich, C. Matthies, I. Isaias, J. Volkmann (Wuerzburg, Germany)

12:00pm-1:30pm: Dopamine reduces Parkinson’s tremor through increased thalamic inhibition

M.F. Dirkx, H.E. den Ouden, E. Aarts, M. Timmer, B.R. Bloem, I. Toni, R.C. Helmich (Nijmegen, Netherlands)

12:00pm-1:30pm: Dopaminergic and metabolic network activities in onset-related subtypes of Parkinson’s disease: A dual-tracer positron emission tomography study

F.T. Liu, J.J. Ge, J.J. Wu, Z.T. Ding, C.T. Zuo, J. Wang (Shanghai, People's Republic of China)

12:00pm-1:30pm: Dopaminergic medication affects choice bias in Parkinson’s disease

A.J.M. van Nuland, R.C.G. Helmich, M. Dirkx, H. Zach, B.R. Bloem, I. Toni, R. Cools, H.E.M. den Ouden (Nijmegen, Netherlands)

12:00pm-1:30pm: DTI in Parkinson’s disease: Asymmetric progression

L. Chan, K. Ng, C. Yeoh, H. Rumpel, E. Tan (Singapore, Singapore)

12:00pm-1:30pm: Dynamic dopamine transporter images are helpful for diagnosing parkinsonism

K. Abe, K. Fukushima, T. Katuura, K. Kitajima, Y. Maeda, K. Hahiskawa, H. Yoshikawa (Nishinomiya, Japan)

12:00pm-1:30pm: Effectiveness of Levodopa responsiveness of Blink reflex recovery: An objective method to differentiate Parkinsonian syndromes

C. Gaddipati, M. Umaiorubahan, C.U. Velmurugendran, V. Shankar (Chennai, India)

12:00pm-1:30pm: Evaluating quantitative EEG (QEEG) measures to differentiate between Parkinson’s disease (PD) patients and healthy individuals

M. Chaturvedi, F. Hatz, U. Gschwandtner, V. Roth, P. Fuhr (Basel, Switzerland)

12:00pm-1:30pm: Excessive daytime sleepiness is mediated by loss of caudate dopaminergic function in Parkinson’s disease

T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

12:00pm-1:30pm: Exploring structural covariance networks of gray matter in Parkinson’s disease

L.J. de Schipper, J. van der Grond, J. Marinus, J.J. van Hilten (Leiden, Netherlands)

12:00pm-1:30pm: Freezing of gait (FOG) in PD: Is electroencephalography (EEG) a gateway to elucidating the pathophysiology?

T. Munteanu, E.J. Baird, C. Fearon, S.M. Waechter, C. McDonnell, J. Gallego, B. Quinlivan, I. Killane, J.S. Butler, T. Lynch, R.B. Reilly (Dublin, Ireland)

12:00pm-1:30pm: Frontal cortex grey matter integrity determines motor improvement after STN-DBS in patients with Parkinson’s disease

M. Muthuraman, G. Deuschl, C. Riedel, J. Volkmann, S. Groppa (Mainz, Germany)

12:00pm-1:30pm: Functional connectivity alterations in Parkinson’s disease patients with impulsive control disorders

A. Campabadal, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, C. Uribe, A.I. Garcia-Diaz, A. Abos, C. Junque (Barcelona, Spain)

12:00pm-1:30pm: Functional connectivity underpinnings of fatigue in “drug-naïve” patients with Parkinson’s disease

A. Giordano, R. De Micco, G. Caiazzo, A. Russo, M. Cirillo, F. Esposito, G. Tedeschi, A. Tessitore (Naples, Italy)

12:00pm-1:30pm: Functional connectome organization is altered in PD patients with mild cognitive impairment

S. Galantucci, F. Agosta, I. Stankovic, S. Basaia, T. Stojkovic, E. Stefanova, E. Canu, A. Meani, V.S. Kostic, M. Filippi (Milan, Italy)

12:00pm-1:30pm: Functional deficits during response inhibition improve after dopaminergic medication for Parkinson

C. Vriend, J.P. Trujillo, N.J.H.M. Gerrits, H.W. Berendse, Y.D. van der Werf, O.A. van den Heuvel (Amsterdam, Netherlands)

12:00pm-1:30pm: Gray/white matter contrast loss correlates with clinical severity and visuospatial impairment in Parkinson’s disease patients

C. Uribe, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, A.I. Garcia-Diaz, A. Campabadal, A. Abos, C. Junque (Barcelona, Spain)

12:00pm-1:30pm: How does preprocessing affect estimation of causal information transfer in the human brain?

I. Weber, E. Florin, F. Jung, M. von Papen, L. Timmermann (Cologne, Germany)

12:00pm-1:30pm: Impact of chronic LD treatment on metabolism, blood flow and blood-brain barrier permeability in the 6-OHDA rat model

R.P. Lerner, Z. Bimpisidis, V. Jourdain, T. Chaly, M. Hellman, K. Graf, V. Dhawan, S. Dewey, A. Cenci, D. Eidelberg (Manhasset, NY, USA)

12:00pm-1:30pm: Impact of datscan on clinical decision making: diagnosis and management of clinically uncertain Parkinsonian syndromes

J.R. Isaacson, N. Chhabria, S.H. Isaacson (Boca Raton, FL, USA)

12:00pm-1:30pm: Impact of white matter hyperintensity on motor compensation in Parkinson’s disease

J.J. Lee, Y. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Korea)

12:00pm-1:30pm: Impaired cerebellum to motor cortex associative plasticity in Parkinson’s disease

M.K. Lu, C.M. Chen, J.R. Duann, C.H. Tsai (Taichung, Taiwan)

12:00pm-1:30pm: Impaired temporal coupling of action and perception in Parkinson’s disease

E. Pretegiani, N. Vanegas-Arroyave, E. FitzGibbon, M. Hallett, L.M. Optican (Bethesda, MD, USA)

12:00pm-1:30pm: Improvement of saccade amplitude by the STN DBS and visual target eccentricity

A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)

12:00pm-1:30pm: Increased cortical control of gait in patients with Parkinson’s disease and freezing of gait

G.J. Revuelta, C. Chan, S. Jenkins, J. Jensen, L. Bonilha (Charleston, SC, USA)

12:00pm-1:30pm: Inferring the coupling of motor related brain areas during paced finger tapping in Parkinson’s patients

V. Seeger, F. Jung, L. Schneider, T.A. Dembek, P. Reker, N. Apetz, M. Tittgemeyer, L. Timmermann (Cologne, Germany)

12:00pm-1:30pm: Influence of different spike sorting algorithms on the detection of single unit spiking activity in the subthalamic nucleus of patients with Parkinson’s disease

J. Sukiban, R. Pauli, T.A. Dembek, I. Weber, F. Jung, N. Voges, M. Denker, S. Gruen, L. Timmermann (Cologne, Germany)

12:00pm-1:30pm: Influence of lateral wedges on postural control in patient with Parkinson’s disease

J. Park, J. Yoon, W. Jang, J.S. Kim, J. Youn, E.S. Oh (Busan, Korea)

12:00pm-1:30pm: Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus

B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)

12:00pm-1:30pm: Is it just a coincidence? Three new cases of Parkinson’s disease associated with myasthenia gravis

G. Sciacca, A. Nicoletti, E. Reggio, G. Mostile, M. Zappia (Catania, Italy)

12:00pm-1:30pm: Is the defective gait automaticity associated to deficiencies in implicit learning in patients with Parkinson’s disease?

M.E.P. Piemonte, A.F. Helene, B. Monte, E.N. Guelfi, E. Okamoto, C. Vargas, J.A. Galves (Sao Paulo, Brazil)

12:00pm-1:30pm: Is the selection of stepping impaired in PD in ON state?

C. Stummer, E. Mallia, J. Rothwell, B.R. Bloem, V. Weerdesteyn (Nijmegen, Netherlands)

12:00pm-1:30pm: Lessons-experienced in the creation of a global public-private consortium with the goal of advancing treatments that hold most potential for delayed disease progression in Parkinson’s disease – Critical path for Parkinson’s (CPP)

V.D. Kern, D.T. Stephenson, K. Romero, E. Avilés, S.T. Broadbent, S.P. Arneric, L. Barbieri, S. Ford, A. Roach (Tucson, AZ, USA)

12:00pm-1:30pm: Magnetic resonance imaging of nigrosome-1 in the diagnosis of early Parkinson’s: Initial results of the Parkinson’s magnetic imaging repository (PaMIR)

S.T. Schwarz, Y. Xing, A. Martin Bastida, C. Lakmali Sugathapala, M. Silverdale, J. Mclean, R. Jampana, N. Bajaj, D. Burn, P. Piccini, D. Grosset, D.P. Auer (Nottingham, United Kingdom)

12:00pm-1:30pm: May substantia nigra volume asymmetry be an indicator of motor asymmetry in Parkinson’s disease? A retrospective analysis

N.F. Durmaz, M. Yorubulut, C.M. Akbostanci (Ankara, Turkey)

12:00pm-1:30pm: Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients

M. Trošt, S. Brezovar, C.C. Tang, D. Eidelberg, N. Zupancic Kriznar, M. Gregoric Kramberger, P. Tomše, Z. Pirtošek (Ljubljana, Slovenia)

12:00pm-1:30pm: Modulation of local field potentials during gait in the STN of patients with Parkinson’s disease

F. Hell, J.H. Mehrkens, A. Plate, K. Bötzel (München, Germany)

12:00pm-1:30pm: Motor subtypes in Parkinson’s disease are distinguished by alterations in morphology and white matter integrity

G. Vervoort, I. Leunissen, M. Firbank, E. Heremans, E. Nackaerts, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

12:00pm-1:30pm: Movement related beta oscillatory activity during self-paced wrist movement in the human subthalamic nucleus

P. Zhuang, R. Chen, M. Hallett, Q. Cui, Y. Zhang, J. Li, Y. Li (Beijing, People's Republic of China)

12:00pm-1:30pm: MRI signatures of the brain of Parkinson’s disease and idiopathic REM sleep behavioral disorder subjects

P. Tuite, S. Mangia, P. Burton, A. Svatkova, I. Nestrasil, A. Sierra Lopez, K. Shmueli, L. Eberly, M. Howell, S. Michaeli (Minneapolis, MN, USA)

12:00pm-1:30pm: Multi-modal imaging in Parkinson’s disease patients with freezing of gait

J.M. Hall, C. O'Callaghan, J.M. Shine, M. Gilat, C.C. Walton, K.A. Ehgoetz Martens, A.A. Moustafa, S.J.G. Lewis (Milperra, Australia)

12:00pm-1:30pm: Negative emotional signals impair isometric force control in Parkinson’s disease

R.L. Blakemore, M.R. MacAskill, R. Shoorangiz, T.J. Anderson (Christchurch, New Zealand)

12:00pm-1:30pm: Neural mechanisms underlying step initiation failure in patients with Parkinson’s disease and freezing of gait

M. Gilat, M. Georgiades, J.M. Shine, K.A. Ehgoetz Martens, C.C. Walton, J.M. Hall, S.J.G. Lewis (Sydney, Australia)

12:00pm-1:30pm: Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson’s disease: A resting state functional MRI study

M.C. Wen, S.Y.E. Ng, H.S.E. Heng, Y. Chao, L.L. Chan, E.K. Tan, L.C.S. Tan (Singapore, Singapore)

12:00pm-1:30pm: Neuromelanin-MRI of substantia nigra subregions in Parkinson’s disease

L. Borellini, G. Franco, P. Trujillo, P. Summers, A. Di Fonzo, D.O. Claassen, A. Costa (Milan, Italy)

12:00pm-1:30pm: Nigrostriatal degeneration and serum BDNF levels in patients with “de novo” untreated Parkinson’s disease

G. Marti, N. Saez, M. Corominas, G. Cuberas, C. Lorenzo, O. De Fabregues, J. Alvarez-Sabin, M. Casas, J. Hernandez (Barcelona, Spain)

12:00pm-1:30pm: Novel PET Tracers of alpha-synuclein for the diagnosis of Parkinson’s disease

E. Tsika, A. Davranche, J. Molette, E. Gabellieri, S. Papin, S. Nampally, H. Kroth, D. Lowe, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

12:00pm-1:30pm: Olfactory performance and resting state functional connectivity in non-demented drug naïve patients with Parkinson’s disease

M. Sunwoo, J.H. Ham, J.Y. Hong, Y.H. Sohn, P.H. Lee (Seongnam, Korea)

12:00pm-1:30pm: Onset-related subtypes of Parkinson’s disease differ in the patterns of striatal functional connectivity: A resting-state functional MRI study

Y. Hou, J. Yang, C. Luo, R. Ou, W. Song, Q. Gong, H. Shang (Chengdu, People's Republic of China)

12:00pm-1:30pm: Pain-motor integration in the primary motor cortex in Parkinson’s disease

A. Suppa, C. Leone, F. Di Stasio, A. Biasiotta, L. Marsili, S. La Cesa, A. Di Santo, G. Fabbrini, G. Cruccu, A. Berardelli (Rome, Italy)

12:00pm-1:30pm: Pallidal DBS and pallidotomy alter cortical synchronization in Parkinson’s disease

S. Miocinovic, C. De Hemptinne, A. Miller, J.L. Ostrem, P.A. Starr (San Francisco, CA, USA)

12:00pm-1:30pm: Parkinson’s disease-linked mutation in DNAJC13 causes specific trafficking defect in endosomal pathway

S. Yoshida, T. Hasegawa, R. Oshima, J. Kobayashi, N. Sugeno, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)

12:00pm-1:30pm: Prognostic factors of motor symptoms in Parkinson’s disease using neuromelanin imaging and the relationship with (123)I-FP-CIT-SPECT

A. Okuzumi, T. Hatano, K. Kamagata, M. Hori, S. Aoki, N. Hattori (Tokyo, Japan)

12:00pm-1:30pm: Progressive atrophy of parahippocampal gyrus correlates with Hoehn & Yahr stages of Parkinson’s disease: A voxel based morphometric study

P.K. Pal, R.M. Naduthota, L. George, K. Jhunjhunwala, J. Saini, R.D. Bharath, A. Lenka, R. Yadav (Bangalore, India)

12:00pm-1:30pm: Pronounced beta oscillations are a characteristic of the cortico-basal ganglia loop of subacute and chronic animal models of Parkinson´s disease

C. van Riesen, J.K. Haumesser, J. Kühn, A. Kühn, M.H. Beck (Berlin, Germany)

12:00pm-1:30pm: Recruitment of single subthalamic neurons for kinematic control of hand and feet movements employs different strategies

A. Tankus, A. Mirelman, N. Giladi, I. Fried, J.M. Hausdorff (Tel-Aviv, Israel)

12:00pm-1:30pm: Relation between the clinical features and the standardized heart to mediastinum ratio in cardiac metaiodobenzylguanidine imaging in patients with Parkinson’s disease: A multicenter cross-sectional study

T. Osada, Y. Morita, K. Ohta, S. Nogawa, K. Takahashi, K. Yamaguchi, D. Yasutomi, M. Seki, Y. Nihei, S. Iwasawa, N. Suzuki (Tokyo, Japan)

12:00pm-1:30pm: Relationship between freezing and pedunculopontine nucleus’ size in Parkinson’s disease: Semi quantitative analysis based on MRI with modified FGATIR sequence

S. Chen, M. Tir, P. Monet, J.M. Constans, O. Godefroy, M. Lefranc, P. Krystkowiak (Amiens, France)

12:00pm-1:30pm: Research of vestibular evoked myogenic potentials (VEMP) in the diagnosis of postural instability in Parkinson’s disease

O.A. Alenicova, S.A. Likhachev (Minsk, Belarus)

12:00pm-1:30pm: Resting state functional connectivity in olfactory network in de novo Parkinson’s disease

S. Marino, L. Bonanno, F. Caminiti, F. Corallo, V. Lo Buono, S. De Salvo, G. Di Lorenzo, P. Bramanti (Messina, Italy)

12:00pm-1:30pm: Resting-state functional connectivity of subthalamic nucleus in different phenotypes of Parkinson’s disease

Z. Wang, H. Chen, H. Ma, L. Ma, T. Wu, T. Feng (Beijing, People's Republic of China)

12:00pm-1:30pm: Sensory and motor aspects of rhythmic entrainment in Parkinson’s disease

E.S. te Woerd, R. Oostenveld, F.P. de Lange, P. Praamstra (Nijmegen, Netherlands)

12:00pm-1:30pm: Spectral analysis of rapid eye movement (REM) sleep as a potential marker of neurodegenerative disease in REM sleep behavior disorder

J. Rodrigues Brazète, J.F. Gagnon, R.B. Postuma, P.A. Bourgouin, D. Petit, J. Montplaisir (Montreal, QC, Canada)

12:00pm-1:30pm: Substantia nigra hyperechogenicity in Mexican patients with Parkinson’s disease

C.Y. Rodriguez-Garza, A. Anaya-Escamilla, R. Pinales-Razo, I. Estrada-Bellmann, C.R. Camara-Lemarroy (Monterrey, Mexico)

12:00pm-1:30pm: Substantia nigra hyperechogenicity in Parkinson´s disease motor phenotypes

T. Toomsoo, A.H. Pool, I. Liepelt–Scarfone, L. Kadastik-Eerme, T. Asser, D. Berg, P. Taba (Tallinn, Estonia)

12:00pm-1:30pm: Suppression of dyskinesia in Parkinson’s disease by electrical stimulation of dorsal subthalamic nucleus tissue

H.A.C. Wark, G.H. Duffley, C.R. Butson, L.E. Schrock (Salt Lake City, UT, USA)

12:00pm-1:30pm: Targeted over-expression with AAV-mediated human α-synuclein in a rat model of Parkinson’s disease – Validation of novel fine motor functional effects

R. Pussinen, T. Ahtoniemi, T. Huhtala, O. Kontkanen, A. Nurmi (Kuopio, Finland)

12:00pm-1:30pm: The association between structural brain connectivity with plasma APO-A1 levels in Parkinson’s disease: Connectometry approach

F. Rahmani, M.H. Aarabi (Tehran, Islamic Republic of Iran)

12:00pm-1:30pm: The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson’s disease

B.A. Pickut, W. Van Hecke, P. Cras, E. Kerckhofs, S. Vanneste, D. Crosiers, P. Marien, P.M. Parizel (Grand Rapids, MI, USA)

12:00pm-1:30pm: The effect of dopaminergic therapy on stimulus-response learning and decision-making in Parkinson’s disease using fMRI

P.A. MacDonald, N.M. Hiebert, K.N. Seergobin, A.M. Owen (London, ON, Canada)

12:00pm-1:30pm: The efficacy of quantitative ^99mTc-TRODAT-1 SPECT in diagnosis of aged patients with Parkinson’s disease

C.F. Lee, C.Y. Wei, G.U. Huang, I.J. Chen, B. Hsu (Changhua, Taiwan)

12:00pm-1:30pm: The feasibility of measuring fatigability in early-stage Parkinson’s disease using functional MRI

Y. Xing, N. Bajaj, S.T. Schwarz, D.P. Auer (Nottingham, United Kingdom)

12:00pm-1:30pm: The patient’s perspective: The effect of dopamine on Parkinson symptoms

H. Zach, M.F. Dirkx, J.W. Pasman, B.R. Bloem, R.C. Helmich (Vienna, Austria)

12:00pm-1:30pm: The position of the conus medullaris and the prevalence of isolated lipoma of filum terminale in Parkinson’s disease

H. Mori, K. Shindo (Kurashiki, Japan)

12:00pm-1:30pm: The relationship among clinical features, DAT scintigraphy and MIBG cardiac scintigraphy in patients with Parkinson’s disease

J. Ebina, T. Sekiguchi, M. Takahashi, A. Inaba, S. Orimo (Tokyo, Japan)

12:00pm-1:30pm: The role of cathepsin L involved in the activation of microglia and Parkinson’s disease

S. Xu, X. Yang, H. Zhang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)

12:00pm-1:30pm: The role of striatal dopaminergic terminals in early de novo PD patients with speech impairment

S. Polychronis, G. Pagano, M. Politis (London, United Kingdom)

12:00pm-1:30pm: The role of the frontal lobe in complex walking among healthy older adults and patients with Parkinson’s disease: An fNIRS study

A. Mirelman, I. Maidan, F. Nieuwhof, H. Bernad-Elazari, M.F. Reelick, B.R. Bloem, N. Giladi, J.E. Deutsch, J.A.H.R. Claassen, J.M. Hausdorff (Tel Aviv, Israel)

12:00pm-1:30pm: Tracking Parkinson’s disease over 2-6 years with MRI

T.R. Melzer, D.J. Myall, M.R. MacAskill, L. Livingston, T.L. Pitcher, K. Wood, R.J. Keenan, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

12:00pm-1:30pm: Transcranial sonography of the substantia nigra and its correlation with iron metabolism and c-reactive protein in Parkinson’s disease

X. Yang, J. Liu, Y. Qian, S. Xu, Q. Xiao (Shanghai, People's Republic of China)

12:00pm-1:30pm: Transcranial static magnetic field stimulation (tSMS) decreases motor cortex excitability in Parkinson’s disease OFF but not ON medication

M. Dileone, M. Carrasco-López, J. Segundo-Rodriguez, L. Mordillo-Mateos, N. López-Aristegui, F. Alonso-Frech, M. Catalan-Alonso, J. Obeso, A. Oliviero, G. Foffani (Madrid, Spain)

12:00pm-1:30pm: Ultra high field magnetic resonance imaging of nigrosome 1 is a biomarker of new onset and premotor Parkinson’s disease

M.A. Brodsky, J.M. Pollock, J. Grinstead, D. Lahna, D. Pettersson, W.D. Rooney (Portland, OR, USA)

12:00pm-1:30pm: Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease

A. Shalash, D. Hassan (Cairo, Egypt)

12:00pm-1:30pm: Visual hallucination and pattern of brain degeneration in Parkinson’s disease

W.W. Lee, E.J. Yoon, J.Y. Lee, S.W. Park, Y.K. Kim (Seoul, Korea)

12:00pm-1:30pm: Visual vs. automated analysis of [123I]FP-CIT SPECT scans in patients with parkinsonism

E. Mäkinen, J. Joutsa, J. Johansson, M. Mäki, M. Seppänen, V. Kaasinen (Turku, Finland)

12:00pm-1:30pm: What predicts Parkinson’s disease? Hyposmia, MIBG SPECT, DAT SPECT and the PD-specific metabolic pattern

S.K. Meles, D. Vadasz, R.J. Renken, K.M. Eggert, E. Sittig-Wiegand, C. Depboylu, V. Ries, G. Mayer, K. Reetz, S. Overeem, A. Pijpers, H. Höffken, M. Luster, K. Kesper, W. Oertel, K.L. Leenders (Groningen, Netherlands)

« View all sessions from the 20th International Congress.